Testing a new mitral valve repair device for high-surgery-risk patients
Part of Heart & circulation clinical trials.
This study looks at a new way to treat a leaky mitral heart valve using the INNOVALVE system. It’s meant for people who have symptoms from mitral regurgitation but are considered high risk for open-heart surgery, to see if the approach can help safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a leaky mitral valve (mitral regurgitation) that is causing symptoms and is considered clinically significant
- Your heart condition makes you a high risk for traditional open-heart surgery
- Your heart and valve shape must fit the study’s anatomical requirements for the device
- You are not considered unable to have the procedure (not inoperable)
- Your heart pumping strength (ejection fraction) must be 25% or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This trial tests a new device called AMEND™ that is placed through a vein in the leg to repair a leaky mitral valve without open-heart surgery. It is for people with significant mitral regurgitation who are at high risk for surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This early-stage trial tests a new device called the ReValve System that replaces a damaged mitral valve (the valve that controls blood flow in your heart). The study is for people with a weakened heart who have leaking mitral valves and are experiencing heart failure symptoms.
Hear when a new Mitral Valve Regurgitation (Degenerative or Functional) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.